Harmke A. Van Kooten

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Unfavorable cardiovascular risk profile without increased event prevalence in late-onset Pompe disease: an individually matched cohort study.

Unfavorable cardiovascular risk profile without increased event prevalence in late-onset Pompe disease: an individually matched cohort study.

Journal: Orphanet journal of rare diseases

Published: September 22, 2025

Antibody formation and efficacy of enzyme replacement therapy in adults with Pompe disease: Unlocking long-term insights.

Antibody formation and efficacy of enzyme replacement therapy in adults with Pompe disease: Unlocking long-term insights.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 15, 2025

Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale.

Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale.

Journal: European journal of neurology

Published: December 24, 2023

Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review.

Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review.

Journal: Biomolecules

Published: July 14, 2023

Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions.

Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: May 21, 2023

MRI changes in diaphragmatic motion and curvature in Pompe disease over time.

MRI changes in diaphragmatic motion and curvature in Pompe disease over time.

Journal: European radiology

Published: February 10, 2022

Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease.

Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease.

Journal: Orphanet journal of rare diseases

Published: November 01, 2021

Chest MRI to diagnose early diaphragmatic weakness in Pompe disease.

Chest MRI to diagnose early diaphragmatic weakness in Pompe disease.

Journal: Orphanet journal of rare diseases

Published: July 05, 2020

Cardiovascular disease in non-classic Pompe disease: A systematic review.

Cardiovascular disease in non-classic Pompe disease: A systematic review.

Journal: Neuromuscular disorders : NMD

Published: May 14, 2020

Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients.

Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients.

Journal: Orphanet journal of rare diseases

Published: April 16, 2020

Discontinuation of enzyme replacement therapy in adults with Pompe disease: Evaluating the European POmpe Consortium stop criteria.

Discontinuation of enzyme replacement therapy in adults with Pompe disease: Evaluating the European POmpe Consortium stop criteria.

Journal: Neuromuscular disorders : NMD

Published: June 13, 2019

The appropriateness of surveillance colonoscopy intervals after polypectomy.

The appropriateness of surveillance colonoscopy intervals after polypectomy.

Journal: Canadian journal of gastroenterology = Journal canadien de gastroenterologie

Published: February 05, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026